Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 119.4%
Virax Biolabs Group (NASDAQ:VRAX) Stock Price Up 119.4%
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Rating)'s share price rose 119.4% during mid-day trading on Monday . The stock traded as high as $13.75 and last traded at $11.85. Approximately 57,188,768 shares changed hands during trading, an increase of 415% from the average daily volume of 11,097,444 shares. The stock had previously closed at $5.40.
Virax Biolabs Group Stock Performance
About Virax Biolabs Group
(Get Rating)
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name.
Further Reading
- Get a free copy of the StockNews.com research report on Virax Biolabs Group (VRAX)
- Proposed Tesla Stock Split Drives EV Market Higher
- AutoNation Stock is Firing on All Pistons
- Is Nike An Undervalued Opportunity for Investors?
- Caterpillar Falls To Strong Support Near Bottom Of Range
- AMD Q2 Earnings Beat Expectations Significantly, Is AMD A Buy?
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
Virax Biolabs Group Limited (NASDAQ:VRAX – Get Rating)'s share price rose 119.4% during mid-day trading on Monday . The stock traded as high as $13.75 and last traded at $11.85. Approximately 57,188,768 shares changed hands during trading, an increase of 415% from the average daily volume of 11,097,444 shares. The stock had previously closed at $5.40.
Virax Biolabs Group Limited(纳斯达克代码：VRAX-GET Rating)周一午盘股价上涨119.4%，盘中一度涨至13.75美元，最新报11.85美元。全天约57,188,768股易手，较11,097,444股的日均成交量增加415%。该股此前收盘价为5.4美元。
Virax Biolabs Group Stock Performance
Virax Biolabs集团股票表现
About Virax Biolabs Group
关于Virax Biolabs集团
(Get Rating)
(获取评级)
Virax Biolabs Group Limited, a biotechnology company, sells, distributes, and markets diagnostics test kits, and med-tech and PPE products for the prevention, detection, diagnosis, and risk management of viral diseases in the field of immunology. The company offers rapid antibody IgC/IgM tests, antigen tests, polymerase chain reaction rapid tests, and neutralizing antibody tests under the ViraxClear brand name; and med-tech and PPE products, such as employee protection equipment products under the ViraxCare brand name.
Virax Biolabs Group Limited是一家生物技术公司，销售、分销和营销诊断试剂盒、医疗技术和个人防护产品，用于预防、检测、诊断和风险管理免疫学领域的病毒疾病。该公司提供ViraxClear品牌下的快速抗体IGC/IgM检测、抗原检测、聚合酶链式反应快速检测和中和抗体检测，以及医疗技术和个人防护产品，如ViraxCare品牌下的员工保护设备产品。
Further Reading
进一步阅读
- Get a free copy of the StockNews.com research report on Virax Biolabs Group (VRAX)
- Proposed Tesla Stock Split Drives EV Market Higher
- AutoNation Stock is Firing on All Pistons
- Is Nike An Undervalued Opportunity for Investors?
- Caterpillar Falls To Strong Support Near Bottom Of Range
- AMD Q2 Earnings Beat Expectations Significantly, Is AMD A Buy?
- 免费获取StockNews.com关于Virax Biolabs Group(VRAX)的研究报告
- 拟议的特斯拉股票拆分推动电动汽车市场走高
- AutoNation股票正在向所有活塞开火
- 耐克对投资者来说是一个被低估的机会吗？
- 卡特彼勒跌至接近区间底部的强劲支撑
- AMD第二季度收益显著超出预期，AMD A买入吗？
Receive News & Ratings for Virax Biolabs Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Virax Biolabs Group and related companies with MarketBeat.com's FREE daily email newsletter.
接受Virax Biolabs Group Daily的新闻和评级-在下面输入您的电子邮件地址，通过MarketBeat.com的免费每日电子邮件时事通讯接收Virax Biolabs Group和相关公司的最新新闻和分析师评级的每日摘要。
译文内容由第三方软件翻译。
风险及免责提示
- 分享到weixin
- 分享到qq
- 分享到facebook
- 分享到twitter
- 分享到微博
- 粘贴板
使用浏览器的分享功能，分享给你的好友吧